This simple three-question test, called “ID Migraine,” can identify patients with migraine with about the same accuracy as widely used screening tests for other illnesses. It was developed by a team of migraine researchers and validated in a national study.
The authors tested the validity and reliability of ID Migraine at 27 primary care sites and 12 headache specialty practice sites in the U.S.
The findings were published in the scientific/clinical journal, Neurology, in August, 2003. The lead author was, Richard B. Lipton, M.D. Professor and Vice Chair of Neurology at the Albert Einstein College of Medicine. Co-authors of the paper were: K. Kolodner, D. Dodick, R. Sadovsky, J. Endicott, J. Hettiarachchi and W. Harrison. The study was supported by funding from Pfizer Inc.
Please submit the following information to receive your assessment:
ROMC
1710 Churn Creek
Redding, CA 96002
P: 530-646-4242
F: 530-646-4243
info@reddingoccmed.com
ROMC strives to be where you need us, when you need us.
ROMC has sister companies located in Emeryville and Santa Cruz, CA.
Contact ROMC for more information.
Hours: Monday - Friday (8:00 AM - 6:00 PM) | Saturday - Sunday (8:00 AM - 3:30 PM)